Eric Morrow told his doctor about his family history of prostate cancer and asked if he needed testing. His doctor said no.

Johnson & Johnson has reported data from a Phase I trial of pasritamig for metastatic castration-resistant prostate cancer ...

This finding implicates that targeting PCNA/AR interaction could be an innovative strategy for therapy against CRPC."BUFFALO, ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

The latest results, which J&J shared at the 2025 American Society of Clinical Oncology (ASCO) annual meeting in Chicago this ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But ...

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

A multiomic approach for detecting clinically significant prostate cancer in seminal fluid: Results from a large multicenter clinical study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...

Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...

Dr. Cheryl Matter shares expert insights into the role physician education can play in ensuring innovative tools reach patients and help improve patient care.